Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal JOPS (Journal Of Pharmacy and Science)
Neni Frimayanti
Sekolah Tinggi Ilmu Farmasi Riau, Jl. Kamboja, Simpang Baru-Panam-Pekanbaru, 28293, Indonesia
Biochemistry, Genetics & Molecular Biology Health Professions Immunology & microbiology Medicine & Pharmacology Public Health

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Cost-Effectiveness Analysis of Erythropoietin in Anemia Therapy Strategies for Chronic Kidney Disease Patients Undergoing Hemodialysis: A Systematic Review Rosi Ami Sari; Seftika Sari; Dwi Endarti; Neni Frimayanti
JURNAL FARMASI DAN MAKANAN Vol 8 No 1 (2024): Journal of Pharmacy and Science
Publisher : LPPM Universitas Abdurrab

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Chronic kidney disease is a significant health issue, with increasing case numbers leading to higher treatment costs. This condition causes decreased kidney function and can result in anemia due to impaired red blood cell production. This study aims to analyze the cost-effectiveness of anemia treatment using Erythropoietin, either as a single therapy or in combination, for patients with chronic kidney failure undergoing hemodialysis. The methods employed include conducting a systematic review to identify problems, establish inclusion and exclusion criteria, and search various databases for relevant studies. The results show that cost-effectiveness varies depending on the Hemoglobin target and the type of Erythropoietin used. In conclusion, setting an appropriate Hemoglobin target and selecting the correct type of Erythropoietin are crucial for effective anemia treatment. This systematic review recommends a Hemoglobin target of >10–11 g/dL and the use of Erythropoietin is adjusted to the patient's condition so that the choice is more cost effective.
Co-Authors Dwi Endarti Rosi Ami Sari Seftika Sari